Brazil IVD Market Analysis provides useful information to business planners including market size estimates for various segments, forecasts, competitive analysis, corporate profiles, market share and other information on the Brazilian laboratory market and its influences. The focus is on the IVD discipline including reagents, consumables, calibrators and controls of market segments, including:
Brazil IVD Sales by Market Segment, 2016-2021 (Clinical Chemistry, Immunoassay, Microbiology/Molecular, POC, Histology, Other, Total)
Brazil IVD Sales by Market Segment, 2016 Market Distribution (%) (Clinical Chemistry, Immunoassays, Microbiology/Molecular, POC, Histology, Other)
Brazil - Clinical Chemistry Revenues, 2016-2021
Brazil - Immunoassay Revenues Distribution, 2016-2021 (%) (Infectious Disease, Other, Total Immunoassay)
Brazil - Immunoassay Revenues by Segment, 2016 vs. 2021 (Infectious Disease, Other)
Brazil - Microbiology/Molecular Testing Revenues Distribution, 2016-2021 (%) (Infectious Disease, Other, Total Microbiology/Molecular Testing)
Brazil Microbiology/Molecular Testing Revenues by Segment, 2016 vs. 2021 (Infectious Disease, Other)
Brazil POC Revenues by Segment, 2016 vs. 2021 (POC Glucose, POC Infectious Disease, Others)
Brazil - Histology Revenues, 2016-2021
Brazil IVD Market Analysis notes trends influencing the opportunity and country-level information including incidence of disease, life expectancy, population demographics, economic status, healthcare utilization and other business influences.
The several global manufacturers that command Brazil's IVD market, including Abbott Laboratories, Danaher Corporation, and Roche (F. Hoffman-La Roche, Ltd.), are profiled in the report. The information in Brazil IVD Market Analysis was gathered using both primary and secondary research methods, including more than 25 interviews completed during the period of April 2017 and June 2017.
Search inside this report
Departmental Site License (one location, up to 10 users)